# Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus

> **NCT06855615** · PHASE4 · COMPLETED · sponsor: **Hospital Sultanah Aminah Johor Bahru** · enrollment: 44 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DRUG:** Mixtard® 30 TDS
- **DRUG:** Insulatard® once daily and thrice daily prandial Actrapid®

## Key facts

- **NCT ID:** NCT06855615
- **Lead sponsor:** Hospital Sultanah Aminah Johor Bahru
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-07-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855615, "Comparison of Thrice-Daily Premixed Human Insulin With Basal-Bolus Therapy Among Patients With Poorly Controlled Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06855615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*